HOME >> MEDICINE >> NEWS
Report 13 in RERF study of mortality of A-bomb survivors extends coverage through 1997

Report 13 in an ongoing series of reports from the Radiation Effects Research Foundation (RERF) on mortality in the Life Span Study (LSS) cohort of A-bomb survivors addresses solid cancer and noncancer disease mortality for the years 1950-1997.

Authored by Dale Preston and his colleagues Yukiko Shimizu, Donald A. Pierce, Akihiko Suyama and Kiyohiko Mabuchi, the study appears in the October issue of Radiation Research.

The authors found that while excess rates for radiation-related cancers have increased throughout the study period, relative risks have declined with increasing attained age. As noted in previous reports, the relative risks are highest for those exposed as children.

No significant difference between cities (Hiroshima and Nagasaki) has been found for either the relative or absolute excess solid cancer risk.

Evidence for radiation effects on noncancer mortality continues to be strong, with statistically significant increases for heart disease, digestive diseases, and respiratory diseases.

The cohort studied consists of over 86,000 people with individual dose estimates, with 60% having doses of at least 5 mSv.


'"/>

Contact: Dale L. Preston
preston@rerf.or.jp
Radiation Research Society
20-Oct-2003


Page: 1

Related medicine news :

1. National Academies advisory: Report assesses health implications of perchlorate exposure
2. Report on health insurance coverage of Iowa children shows gaps
3. Report finds new model of care can improve quality, lower costs and increase physician efficiency
4. Michelle Trudeau wins 2004 Victor Cohn Prize for Excellence in Medical Reporting
5. Oct. 14 Web cast: Reporters Workshop -- Covering Vaccines & Immunizations
6. Latest Public Policy & Aging Report forecasts possible US labor shortage
7. Report finds inactivated influenza virus vaccines effective in children
8. Microneedles: Report describes progress in new technology for painless drug delivery
9. Report gives NIH-sponsored clinical research a good report card
10. Report cites risks associated with over-the-counter cosmetic contact lenses
11. Report shows high arsenic in some southeast NH private wells

Post Your Comments:
(Date:7/21/2014)... kill cancer cells could boost the effectiveness of chemotherapy ... a new study reports. , Scientists at The Institute ... genetically engineered version of the virus used to vaccinate ... alongside isolated limb perfusion chemotherapy given directly to ... an alternative to amputation was more effective in ...
(Date:7/21/2014)... July 22, 2014 On Monday, September 22, ... Golf Outing honoring Mike McGuriman-Motorola Solutions at The Knoll West ... begins with registration and lunch at 11 a.m. The ... prizes. Price increases to $250 after September 7th. ... $100 per person. The dinner will include a special ...
(Date:7/21/2014)... July 22, 2014 MillionaireCasket.com, a well-known casket ... maple caskets to its website. In addition to ... 26 percent off) for all these brand new items. ... it provides great caskets for its current and ... mahogany caskets, and oak caskets and more. According to the ...
(Date:7/21/2014)... As reported by CBS Local Pittsburgh in the article ... (7/15), thrill-seeking participants raised $100,000 to raise drug abuse ... Philly. 100 people, including some well-known local news reporters, ... Hotel. Some of the participants shared stories of their ... son killed himself after a long battle with addiction. ...
(Date:7/21/2014)... Cannabis Now Magazine recently announced that ... summer. During these festivals, they will strengthen their relationship ... resources to attendees in an effort to continue their ... legitimate and beneficial side of cannabis. , The publication ... the Kush Expo in Anaheim, the Champs Trade Show ...
Breaking Medicine News(10 mins):Health News:Viral therapy could boost limb-saving cancer treatment 2Health News:Viral therapy could boost limb-saving cancer treatment 3Health News:7th Annual Push to Walk Golf Outing to Be Held September 22nd 2Health News:Cheap Maple Caskets Recently Added To China Casket Manufacturer MillionaireCasket.com’s Product Line 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 2Health News:100 People Climb Down Building to Raise Drug Addiction Awareness in Philadelphia 3Health News:Cannabis Now Magazine Hits the Marijuana Festival Circuit and Sponsors Two Major Events 2
(Date:7/21/2014)...  Champions Oncology (OTC: CSBR), a company engaged in ... personalize the development and use of oncology drugs, today ... for the fourth quarter and fiscal year ended April ... close. The company will host a conference ... p.m. EDT (1:30 p.m. PDT). To participate in the ...
(Date:7/21/2014)... Decision Resources Group finds that the ... than triple, reaching nearly $12 billion by 2023, ... first disease-modifying therapies (DMTs), a landmark event in ... include the anti-beta-amyloid monoclonal antibodies solanezumab (Eli Lilly) ... inhibitor MK-8931 (Roche/Chugai/MorphoSys)—will earn sales of $7 billion ...
(Date:7/21/2014)... , July 21, 2014 ... is utilizing the CompuMed, Inc. (OTCPink: CMPD) ... improve donor organ recovery. CompuMed Enterprise OPO ... real-time access to its Board-Certified specialists for ...      (Logo: http://photos.prnewswire.com/prnh/20140721/697628) ...
Breaking Medicine Technology:The Alzheimer's Disease Market Is Forecast to Reach Nearly $12 Billion by 2023, Following the Projected Launch of the First Disease-Modifying Therapies 2The Alzheimer's Disease Market Is Forecast to Reach Nearly $12 Billion by 2023, Following the Projected Launch of the First Disease-Modifying Therapies 3Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 2Louisiana Organ Procurement Agency Leveraging CompuMed to Secure More Donor Hearts 3
Cached News: